about
Progress towards gene therapy for cystic fibrosisEDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severityInfection control and the significance of sputum and other respiratory secretions from adult patients with cystic fibrosisEarly detection of Pseudomonas aeruginosa--comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF)Organisms isolated from adults with cystic fibrosisChallenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasisTargeted therapies to improve CFTR function in cystic fibrosisInternational Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxietyElucidation of the RamA regulon in Klebsiella pneumoniae reveals a role in LPS regulationCystic fibrosis.Inflammatory related changes in bone mineral content in adults with cystic fibrosisComparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis.Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro.Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceAn official American Thoracic Society research statement: comparative effectiveness research in pulmonary, critical care, and sleep medicine.Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infectionsAntibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungiToll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells.Drug and light delivery strategies for photodynamic antimicrobial chemotherapy (PACT) of pulmonary pathogens: a pilot study.Treatment adherence and health outcomes in patients with bronchiectasis.PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial resultsBIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs.Comparison of nasal and bronchial epithelial cells obtained from patients with COPDBurkholderia cepacia and cystic fibrosis--50 years on.Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis.The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbationsKeratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury."CF asthma": what is it and what do we do about it?Obesity and the lung: 1. Epidemiology.Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells.Inflammatory and cytotoxic effects of acrolein, nicotine, acetylaldehyde and cigarette smoke extract on human nasal epithelial cells.Development of a diagnostic PCR assay that targets a heat-shock protein gene (groES) for detection of Pseudomonas spp. in cystic fibrosis patients.Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis.Neutrophil cell death, activation and bacterial infection in cystic fibrosis.A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.
P50
Q22306014-ED9DD0E3-66B5-4ABB-9420-3F564CFDC8EEQ24621951-75128706-970F-4E9D-9560-66F953B0C5FAQ24792662-6FDAF56C-EE97-435F-8DD8-B2FC10F50E1BQ24795985-4CC7C3E1-CDDD-4934-932F-1F05977C22F6Q24801361-27EA59D8-267E-490E-90C4-1ADCA08D3801Q26739006-CCA5C8B2-9D0A-45C8-B12B-496663006688Q26781441-CA09151D-FE13-4FE9-85E2-C04752E6A610Q26785374-8F94E21A-AD99-4B82-B4FC-9197FC064076Q28543147-7720414E-F552-4EDB-94BB-5FECB83960C1Q30251439-9564DDF2-1AA6-47BF-8DFC-FADD14008467Q33204318-FAFF6F46-C02D-4AAC-88CA-A8AD354B8326Q33492833-DC4741AF-58FC-4B9C-A1C7-DDDC29FD91B5Q33530241-EB30B213-F292-428C-BD0F-8CE1BCD4156FQ33608587-81CA6BF6-4754-41D9-A9DC-E32D05FF2BDCQ33735726-671E9E92-C777-4910-87F9-D0A3977B8186Q33786154-2AC3580E-57C6-4B37-A42F-C5852CDBF2C8Q33792765-28424253-85CA-4FD1-B719-D031AA83C277Q33816648-7AB5195B-CEA9-479A-965C-68A58B2D9B64Q33824498-E966E714-9AD7-4554-BE2D-9F99C4DF43F6Q33877099-67428945-EF6F-49A2-82C3-6E1155A1DFF2Q33974179-249AA4B7-393E-4C8F-9760-23357C35F1F4Q34058642-D3A60D36-4727-4FE8-A593-DD517E7CDE55Q34132007-00B60EFE-EE1F-4A87-BAC4-959DC3BA096FQ34133948-015A3555-D6DE-4B15-88D4-B5CC0F6B2E56Q34180324-E67BCB74-4F3D-425F-8228-4AEFC849FE13Q34193536-52C3AFBD-F9BE-409C-80EF-39815F9A472EQ34348019-7C96A0EB-28BE-4D4A-91B0-80535790B6D7Q34419701-04424B49-5234-42C3-8843-552829922A7AQ34437958-ED53DE24-CCC2-4097-91A5-5F5E348DCDAAQ34480171-49A59551-9B29-40F2-B4C8-D5CEE20DAA52Q34768021-8976558E-003E-4BDB-8241-4A72B5623AF9Q34790029-0697F154-1450-4F4F-995D-488CBE8FE7A7Q34921154-39F18682-73D4-4ACF-9FBA-9EF7B605969DQ35053358-AC5AFDCA-D89D-4F86-8AE5-A435E4EB87C2Q35104876-3515ED14-9730-4B60-A178-95E73C0BB3F7Q35196529-96A042D3-F803-4C52-941F-1864DB293120Q35230652-D1495BFA-FCE5-48F3-87F0-08E9737FFBA3Q35536551-85FB6F1F-EBDB-413B-B73C-07B807CA2D35Q35537852-FD0F14D0-9FB1-4A3D-B4F7-5E3155202CF2Q35591553-3C8E010B-20CD-46A1-B8D8-5AC2C261FE79
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Stuart Elborn
@ast
Stuart Elborn
@de
Stuart Elborn
@en
Stuart Elborn
@es
Stuart Elborn
@fr
Stuart Elborn
@hy
Stuart Elborn
@nl
Stuart Elborn
@sl
type
label
Stuart Elborn
@ast
Stuart Elborn
@de
Stuart Elborn
@en
Stuart Elborn
@es
Stuart Elborn
@fr
Stuart Elborn
@hy
Stuart Elborn
@nl
Stuart Elborn
@sl
altLabel
Elborn, J. S.
@ast
Elborn, J. S.
@de
Elborn, J. S.
@en
Elborn, J. S.
@es
Elborn, J. S.
@fr
J Stuart Elborn
@en
J. S. Elborn
@de
J. S. Elborn
@en
J. S. Elborn
@fr
J. Suart Elborn
@ast
prefLabel
Stuart Elborn
@ast
Stuart Elborn
@de
Stuart Elborn
@en
Stuart Elborn
@es
Stuart Elborn
@fr
Stuart Elborn
@hy
Stuart Elborn
@nl
Stuart Elborn
@sl
P214
P227
P244
P269
P106
P1153
7005194032
P21
P213
0000 0001 2447 8621
P214
P227
1172322015
P244
nb98071108
P269
P31
P496
0000-0002-2323-442X
P735
P7859
lccn-nb98071108